Cargando…
Multiple Sequential Complications After Sirolimus-Eluting Stent Implantation: Very Late Stent Thrombosis, Stent Fracture, In-Stent Restenosis, and Peri-Stent Aneurysm
A 55-year-old male patient presented with an acute myocardial infarction. A sirolimus-eluting stent (SES) was implanted in the proximal left anterior descending artery (LAD). Eight months later, there was a newly developed distal LAD lesion. An additional SES was implanted. Twenty-eight months after...
Autores principales: | Seol, Sang-Hoon, Kim, Doo-Il, Han, Yang-Chun, Kim, Ki-Hun, Kim, Dong-Kie, Kim, Young-Bok, Kim, Ung, Yang, Tae-Hyun, Kim, Dae-Kyeong, Kim, Dong-Soo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771792/ https://www.ncbi.nlm.nih.gov/pubmed/19949591 http://dx.doi.org/10.4070/kcj.2009.39.10.439 |
Ejemplares similares
-
Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011) -
Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009) -
Reduction of In-Stent Restenosis and Inflammation with One Stent: New Concept of Sirolimus and Ascorbic Acid-Eluting Coronary Stent
por: Ryu, JiWung, et al.
Publicado: (2021) -
State-of-the-Art Stent Technology to Minimize the Risk of Stent Thrombosis and In-Stent Restenosis: Abluminal-Coated Biodegradable Polymer Drug-Eluting Stent
por: Kang, Dong Oh, et al.
Publicado: (2022) -
Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010)